Skip to main content
TipRanks
Go Ultimate75% OFF

Atara Biotherapeutics (AT20) Q4 2022 Earnings Report

0 Followers

DE:AT20 Q4 2022 EPS Results

Actual EPS
-EUR 16.40
Consensus EPS
-EUR 11.84
Beat/Miss
Missed by -EUR 4.56
One Year Ago EPS
-EUR 21.87

DE:AT20 Q4 2022 Revenue Results

Actual Revenue
EUR 201.41K
Expected Revenue
EUR 30.99M
Beat/Miss
Missed by -EUR 30.79M
YoY Revenue Growth
-97.07%

Earnings Announcement Details

Quarter
Q4 2022
Date
02/08/2023
Time
After Close
Conference Call
Wednesday, February 8, 2023
DE:AT20 Upcoming Earnings

Atara Biotherapeutics's next earnings date is estimated for March 1, 2027, based on past reporting schedules.

Q4 2022 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q4 2022 Earnings Slide Deck

Q4 2022 Earnings Call Summary

No earnings call summary is available for this earnings event.

DE:AT20 Earnings History

DE:AT20 earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 01, 20272026 (Q4)-0.03--0.23――
Nov 10, 20262026 (Q3)-0.12-0.14-0.2953.13% (+0.15)
Aug 12, 20262026 (Q2)-0.29-0.290.17-268.42% (-0.46)
May 12, 20262026 (Q1)-0.30-0.263.19-108.29% (-3.45)
Mar 16, 20262025 (Q4)-0.16-0.23-1.0878.99% (+0.86)
Nov 29, 20252025 (Q3)-0.61-0.29-2.6789.08% (+2.38)
Aug 11, 20252025 (Q2)-0.060.17-2.83106.13% (+3.00)
May 15, 20252025 (Q1)-1.803.19-5.24160.87% (+8.43)
Mar 07, 20252024 (Q4)-2.61-1.08-12.7691.50% (+11.67)
Nov 12, 20242024 (Q3)-1.72-2.67-15.0482.24% (+12.37)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed